The FDA approved a pain drug designed to eliminate the risks associated with opioids -- the first new pharmaceutical approach ...
On January 7, 2025, the FDA issued a draft guidance called Considerations for the Use of Artificial Intelligence to Support Regulatory ...
Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a novel treatment to treat autism spectrum ...
Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and effective drugs.
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...
The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...
Cartesian Therapeutics has secured an agreement from the US Food and Drug Administration (FDA) under the Special Protocol ...
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries ... AI and machine learning to every stage of the drug development process. This includes identifying targets in the ...